These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7408344)

  • 1. [Two cases of subclinical myopathy. Is it a trait for malignant hyperthermia? (author's transl)].
    Sunohara N; Takagi A; Nonaka I; Satoyoshi E; Kojima S
    Rinsho Shinkeigaku; 1980 Jun; 20(6):448-54. PubMed ID: 7408344
    [No Abstract]   [Full Text] [Related]  

  • 2. Muscle changes in malignant hyperthermia.
    Hausman R
    J Pathol; 1973 Jul; 110(3):Pv-vi. PubMed ID: 4744080
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and laboratory aspects of malignant hyperthermia in children with special reference to creatine kinase isoenzymes (author's transl)].
    Blume H; Schmidt EW; Cayuela S; Ostheimer U; Perge V; Stankovic R; Wellstein A
    Anaesthesist; 1978 Mar; 27(3):108-14. PubMed ID: 646084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and morphological findings in a case of malignant hyperthermia (author's transl)].
    Faber P; Gullotta F; Koenen FW
    Dtsch Med Wochenschr; 1975 Sep; 100(39):1974-6. PubMed ID: 1157706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant hyperthermia--postoperative changes of serum LDH and CPK isozymes (author's transl)].
    Shimonaka H; Yamamoto M
    Masui; 1981 Feb; 30(2):141-9. PubMed ID: 7277676
    [No Abstract]   [Full Text] [Related]  

  • 6. [Transient normalisation of CK blood levels in patients susceptible to malignant hyperthermia by oral administration of dantrolene (author's transl)].
    Bernhardt D
    Anaesthesist; 1982 May; 31(5):252-4. PubMed ID: 7103034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The King syndrome: malignant hyperthermia, myopathy, and multiple anomalies.
    McPherson EW; Taylor CA
    Am J Med Genet; 1981; 8(2):159-65. PubMed ID: 7282770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Creatinine phosphokinase and adenylate kinase activities in skeletal muscle of malignant hyperthermia susceptible patients (author's transl)].
    Oku S; Britt BA
    Masui; 1981 Aug; 30(8):819-25. PubMed ID: 6275140
    [No Abstract]   [Full Text] [Related]  

  • 9. [Extra-cardial rise of the CPK in the screening of urgent diagnostic (among others, a case of anaesthesia induced myoglobinuria and a case of malignant hypertermia) (author's transl)].
    Bernhardt D; Hörder MH
    Med Klin; 1977 Nov; 72(46):1967-71. PubMed ID: 927298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New aspects in the clinical picture of malignant hyperthermia (author's transl)].
    Junger H; Kuhnle P; Schorer R
    Z Kinderchir Grenzgeb; 1980 May; 30(1):35-7. PubMed ID: 7456684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology of malignant hyperpyrexia.
    Br Med J; 1973 Feb; 1(5848):249. PubMed ID: 4685313
    [No Abstract]   [Full Text] [Related]  

  • 12. [Malignant hyperthermia under general anaesthesia. Abnormal histochemical and electron-microscopic muscle findings in combination with pathological serum-CPK-values evidencing the existence of primary myopathy (author's transl)].
    Bernhardt D; Schiller H
    Anaesthesist; 1973 Aug; 22(8):367-72. PubMed ID: 4270680
    [No Abstract]   [Full Text] [Related]  

  • 13. [Malignant hyperthermia, chronic alcoholism and tubular aggregates (author's transl)].
    Gullotta F; Wierich W; Dieckmann J
    Prakt Anaesth; 1976 Dec; 11(6):410-5. PubMed ID: 1013054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preoperative assay of creatine phosphokinase as a precaution against malignant hyperthermia (author's transl)].
    Varesi M
    Chir Ital; 1978 Dec; 30(6):899-908. PubMed ID: 753545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological and neuropharmacological aspects of malignant hyperpyrexia.
    Ellis FR; Keaney NP; Harriman DG
    Proc R Soc Med; 1973 Jan; 66(1 Pt 1):66-7. PubMed ID: 4690061
    [No Abstract]   [Full Text] [Related]  

  • 16. [Malignant hyperthermia. I. Observations in connection with its pathogenesis and course (author's transl)].
    Plötz J; Braun J; Gericke B
    Anaesthesist; 1980 Feb; 29(2):89-93. PubMed ID: 7377528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Muscular enzyme level disorders and a malignant hyperthermia susceptability test: postoperative study of a patient with elevated CPK].
    Perugini M; Montironi C; Rocchi S
    Minerva Anestesiol; 1998; 64(1-2):45-50. PubMed ID: 9658790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant hyperpyrexia.
    Ellis FR
    Anaesthesia; 1973 May; 28(3):245-52. PubMed ID: 4713948
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of pre-operative creatin phosphokinase (CPK) level--usefulness as a screening test for malignant hyperpyrexia (author's transl)].
    Morikawa S; Murata M; Murata H; Iwai S
    Masui; 1979 Feb; 28(2):187-96. PubMed ID: 423358
    [No Abstract]   [Full Text] [Related]  

  • 20. [Malignant hypothermia, 3 cases (author's transl)].
    Utke G; Quos A; Wegener R
    Zentralbl Chir; 1980; 105(23):1573-82. PubMed ID: 7211003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.